Familial dysbetalipoproteinemia: highly atherogenic and underdiagnosed disorder
Familial dysbetalipoproteinemia (FD) is a genetic, highly atherogenic disorder. The penetrance of FD depends on the patient’s lifestyle and concomitant diseases. Despite the fact that FD was described almost half a century ago, it is still insufficiently studied and is extremely rarely diagnosed. In...
Saved in:
| Main Authors: | A. V. Blokhina, A. I. Ershova, A. N. Meshkov, O. M. Drapkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2893 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FAMILIAL DYSBETALIPOPROTEINEMIA (TYPE III HYPERLIPOPROTEINEMIA)
by: P. P. Malyshev, et al.
Published: (2019-03-01) -
PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center
by: A. V. Blokhina, et al.
Published: (2022-01-01) -
Lipid Clinic is an Efficacious Model of Preventive Medicine
by: A. V. Blokhina, et al.
Published: (2021-03-01) -
MicroRNA-615-3p decreases apo B expression in human liver cells
by: Abulaish Ansari, et al.
Published: (2024-10-01) -
Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism
by: Mahboubeh Hosseini-Kharat, et al.
Published: (2025-03-01)